Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study
- Resource Type
- Article
- Source
- In
The Lancet 13-19 August 2022 400(10351):493-501 - Subject
Primary Research Articles - Language
- ISSN
- 0140-6736